Kim Giffoni, EVP Foreign Sales/Inv. Rel at Targeted Medical Pharma, Inc. (TRGM), bought 11,980 shares at $0.88 ($11K) on 2013-12-11, disclosed to the SEC on 2013-12-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.83 | 3,500 | $3K | 27.6% |
| 2 | $0.90 | 7,480 | $7K | 64.0% |
| 3 | $0.88 | 1,000 | $880 | 8.4% |
| Total | $0.88 avg | 11,980 | $11K | 100% |
| Filing → |
| TRGM | BUY | 2013-12-04 | $5K | — | Filing → |